Manufacturers Life Insurance Company, The I Mab Transaction History

Manufacturers Life Insurance Company, The

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2023	BUY	$8.27 - $18.43 $1.62 Million - $3.62 Million	196,394 Added 40.96%	675,897 $7.64 Million
Q2 2022 Aug 15, 2022	BUY	$8.27 - $18.43 $1.62 Million - $3.62 Million	196,394 Added 40.96%	675,897 $7.64 Million
Q1 2022 Aug 11, 2023	BUY	$12.54 - $46.93 $6.01 Million - $22.5 Million	479,503 New	479,503 $7.79 Million
Q1 2022 May 20, 2022	BUY	$12.54 - $46.93 $18,810 - $70,395	1,500 Added 0.31%	479,503 $7.79 Million
Q4 2021 Feb 16, 2022	SELL	$45.28 - $74.5 $1.85 Million - $3.04 Million	-40,809 Reduced 7.87%	478,003 $22.7 Million
Q3 2021 Nov 12, 2021	SELL	$57.18 - $84.43 $11.3 Million - $16.7 Million	-197,578 Reduced 27.58%	518,812 $37.6 Million
Q2 2021 Aug 12, 2021	SELL	$47.86 - $83.95 $1.25 Million - $2.2 Million	-26,179 Reduced 3.53%	716,390 $60.1 Million
Q1 2021 May 03, 2021	BUY	$44.38 - $63.97 $4.85 Million - $6.98 Million	109,181 Added 17.24%	742,569 $36 Million
Q4 2020 Feb 12, 2021	SELL	$32.94 - $47.15 $6.36 Million - $9.11 Million	-193,172 Reduced 23.37%	633,388 $29.9 Million
Q3 2020 Nov 09, 2020	BUY	$27.46 - $47.03 $604,120 - $1.03 Million	22,000 Added 2.73%	826,560 $38.9 Million
Q2 2020 Aug 10, 2020	SELL	$13.0 - $31.0 $334,958 - $798,746	-25,766 Reduced 3.1%	804,560 $23.1 Million
Q1 2020 May 15, 2020	BUY	$10.63 - $15.37 $8.83 Million - $12.8 Million	830,326 New	830,326 $10.8 Million

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $78.9M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.